galacto-Dapagliflozin Size:Contact [email protected] for quotation Lactacystin also inhibits the lysosomal

Lactacystin also inhibits the lysosomal enzyme cathepsin A

InChi: InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52

CTX- 0294885 represents a powerful new reagent for analysis of kinome signaling networks that may facilitate development of targeted therapeutic strategies

CAS Number: 348-67-4

galacto-Dapagliflozin Size:Contact [email protected] for quotation Lactacystin also inhibits the lysosomalKi = 2 nM galacto Dapagliflozin is a potent inhibitor of human SGLT2. Renal glucose transport is mediated by sodium glucose cotransporters (SGLT) 1 and 2. In humans, SGLT2 is responsible for the majority of glucose reabsorption in the kidney. In vitro: It was found that galacto dapagliflozin was a selective inhibitor of hSGLT2, but was less potent than dapagliflozin for both transporters. Both phlorizin and galacto dapagliflozin rapidly dissociated